Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 46Thoracic 3Other hematologic neoplasm 3Other 3Head & Neck 3Sarcoma 1Plasma cell 1Lymphoid 1Gynecologic 1Genitourinary 1Classical hematology 1Breast 1

Conditions

Ovarian Neoplasms 586Uterine Cervical Neoplasms 497Endometrial Neoplasms 319Breast Neoplasms 140Uterine Cervical Dysplasia 103Neoplasms 102Carcinoma, Ovarian Epithelial 90Fallopian Tube Neoplasms 78Lung Neoplasms 65Colorectal Neoplasms 64Uterine Neoplasms 61Vulvar Neoplasms 56Pancreatic Neoplasms 56Papillomavirus Infections 53Prostatic Neoplasms 52Stomach Neoplasms 49Colonic Neoplasms 47Peritoneal Neoplasms 41Melanoma 39Urinary Bladder Neoplasms 37Carcinoma, Non-Small-Cell Lung 37Esophageal Neoplasms 36Head and Neck Neoplasms 32Vaginal Neoplasms 28Recurrence 28Pelvic Neoplasms 28Rectal Neoplasms 27Ovarian Cysts 27Endometrial Hyperplasia 26Sarcoma 25

Interventions

Sampling Studies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Fibrosis × Gynecologic × Clear all
NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Dana-Farber Cancer Institute

Recruiting
5,000 enrolled
GastrointestinalGynecologicOther hematologic neoplasmThoracic

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡